 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval6 {1 o+ G/ @& F0 M8 H
. J" Z- l! c! Q# @4 G, ^
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.0 m4 q+ F; n; I! q. E! W
( i9 F, e3 |" E, a: N3 ^' \BY THE EDMONTON JOURNAL FEBRUARY 16, 2007: C( ^) v$ h' f; ?: G1 s
! ]. q+ l* I& M& c
9 V q& W' R" O7 u3 v
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX. K- q, q1 m7 y; G8 |
2 G$ c5 L6 S- Z" Q2 A1 ?
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM.", |7 ?. ?$ f- {& t4 |- Q. O ]
' J- B8 ?: \0 L2 i9 K& |The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.; Q8 Y0 ?- s: @: C
# @1 n1 v0 O6 b0 C8 c
It should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
: U7 _( Z1 G; `
& g) s* ?9 O) a5 GIt certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
: s! L- e* @& _/ p4 r J
$ C$ R6 P& K2 X9 D1 P5 q6 v"As a scientist, it's one of the highlights of my CAREER," Shan said.
0 G/ k0 c$ l! @0 B4 {% J2 j v
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention.". F1 c3 n, P6 [" ?4 `6 |8 h
6 e. q; G/ t0 L) C) B2 I/ M7 B
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
9 o% @# x, @% m6 |( n. X; E2 A5 t
! c" d- ^- G P6 S n' yGinseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
4 P8 J$ u( H$ j. E0 u( x8 C" h% n1 g5 S
The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.
% ]8 i; z: B" S& \' d; T; Q
" ^4 J. [; A- [1 W- a" ~1 W8 x/ f5 n' ^1 M: Z5 b
http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
$ i6 }4 N6 N4 ~ m; m, l/ R
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
发表于 2015-2-28 19:45
